Patrick C Hermann

Prof. Dr. Dr.

University Hospital Ulm

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Cancer Biology Cancer Biology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Prof. Dr. Dr. Patrick C Hermann is a faculty member at University Hospital Ulm in Germany. His research focuses on gastrointestinal cancer, particularly the roles of small extracellular vesicles, cancer stem cells, and genetic factors in tumor progression and treatment resistance. He has contributed significantly to studies on the metastatic behavior of pancreatic cancer and the therapeutic potential of various pharmacological interventions.

Articles (10)

Year:

2024

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (4)

Miltiadis Tsesmelis

Universität Ulm

GERMANY

View details

Laura Lerma

Profesora Ayudante Doctora

Universidad Autónoma de Madrid

SPAIN

View details

Emilio González-Arnay

Aggregate Professor

Universidad de la Laguna

SPAIN

View details

Fabian Beier

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Patrick C Hermann

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Emerging Roles of Small Extracellular Vesicles in Gastrointestinal Cancer Research and Therapy

Deletion of NEMO Inhibits EMT and Reduces Metastasis in KPC Mice

Telomerase and Pluripotency Factors Jointly Regulate Stemness in Pancreatic Cancer Stem Cells

The CXCL12 Crossroads in Cancer Stem Cells and Their Niche

Exploiting oxidative phosphorylation to promote the stem and immunoevasive properties of pancreatic cancer stem cells.

Nintedanib plus mFOLFOX6 as second-line treatment of metastatic, chemorefractory colorectal cancer: The randomised, placebo-controlled, phase II TRICC-C study (AIO-KRK-0111).

Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancer.

ISG15 and ISGylation is required for pancreatic cancer stem cell mitophagy and metabolic plasticity.

The Cancer Stem Cell in Hepatocellular Carcinoma.

Pancreatic cancer-derived organoids - a disease modeling tool to predict drug response.

Collaborators (4)

Miltiadis Tsesmelis

Laura Lerma

Emilio González-Arnay

Fabian Beier

Make your next move.